An open letter signed by dozens of medical and public health organizations urges payers and insurers to continue covering COVID vaccines for pregnant patients.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
A study yesterday in JAMA Internal Medicine shows that a fourth Pfizer COVID-19 vaccine dose provided 64% to 67% protection against hospitalization and 72% protection against death in nursing home residents, but only 34% protection against infection during an Omicron-dominated period.
The absolute risk appears to be only slightly higher than in uninfected peers.
Maternal COVID vaccination during pregnancy provides 52% protection against COVID-19 hospitalization in infants but only 38% protection against Omicron hospitalization, according to a study yesterday in the New England Journal of Medicine.
Protection against an intensive care unit (ICU) stay, however, was 70%.
Only 0.74% of patients visited an emergency department and only 0.11% a hospital.
The vaccine produces a strong immune response against the BA.4 and BA.5 Omicron subvariants.
Women had a broader symptom profile than men, who were more likely to have diabetes or kidney problems.
The United Kingdom today expanded monkeypox vaccination to include men who have sex with men who are in high-risk groups, instead of just those who are known contacts and those at occupational risk.
"We know millions of parents and caregivers are eager to get their young children vaccinated."
Rates of Kawasaki disease, a rare acquired cardiac condition in kids, fell nationally during peak COVID-19 transmission when control measures were in place, potentially providing a clue that multiple triggers and upper airway inhalation might be involved.
In global news, WHO advisers weigh in on the composition of modified COVID-19 vaccines to address variants.
